The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease
Open accessAbstract
BACKGROUND: Indoxyl sulphate (IS) and p-cresyl sulphate (PCS) are uraemic toxins that have similar protein binding, dialytic clearance and proinflammatory features. However, only a few prospective studies have evaluated possible associations between these two retained solutes and renal disease progression in chronic kidney disease (CKD) patients. METHODS: This prospective observational study evaluated independent associations between serum total IS and PCS with renal progression in a selected cohort of patients having different stages of CKD. Baseline PCS and IS were correlated with renal progression [defined as decrements in estimated glomerular filtration rate (eGFR) > 50% from baseline or progression to end-stage renal disease (ESRD)] and death during a follow-up period of 24 months. RESULTS: Of 268 patients, 35 (13.1%) had renal progression and 14 (5.2%) died after a mean follow-up of 21 ± 3 months. Univariate Cox regression analysis followed by multivariate analysis showed that high-serum PCS levels were associated with renal progression and all-cause mortality independent of age, gender, diabetes status, albumin levels, serum IS, serum creatinine, Ca × P product, intact parathyroid hormone, haemoglobin or high-sensitivity C-reactive protein level. Serum IS was only associated with renal progression; however, the predictive power of serum IS was weakened when serum PCS was also present in the analytical model. CONCLUSIONS: In addition to traditional and uraemia-related risk factors such as renal function, serum IS and PCS levels may help in predicting the risk of renal progression in patients having different stages of CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Journal of Laboratory and Clinical Medicine
(2003) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(03)00127-6 · Cited by 1,767
Barreto, F. C., Barreto, D. V., Liabeuf, S., Meert, N., Glorieux, G., Temmar, M., Choukroun, G., Vanholder, R., & Massy, Z. A. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03980609 · Cited by 929
The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair
Dou, L., Bertrand, E., Cerini, C., Faure, V., Sampol, J., Vanholder, R., Berland, Y., & Brunet, P. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00399.x · Cited by 489
Meyer, T. W., & Hostetter, T. H. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071313 · Cited by 458
Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis.
Niwa, T., & Ise, M. (1994) · PubMed · Cited by 440
Liabeuf, S., Barreto, D. V., Barreto, F. C., Meert, N., Glorieux, G., Schepers, E., Temmar, M., Choukroun, G., Vanholder, R., Massy, Z. A., et al. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp592 · Cited by 431
Bammens, B., Evenepoel, P., Keuleers, H., Verbeke, K., & Vanrenterghem, Y. (2006) · Kidney International · doi:10.1038/sj.ki.5000115 · Cited by 388
p-Cresol and Cardiovascular Risk in Mild-to-Moderate Kidney Disease
Meijers, B. K. I., Claes, K., Bammens, B., de Loor, H., Viaene, L., Verbeke, K., Kuypers, D., Vanrenterghem, Y., & Evenepoel, P. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07971109 · Cited by 316
Free p-cresol is associated with cardiovascular disease in hemodialysis patients
Meijers, B. K. I., Bammens, B., De Moor, B., Verbeke, K., Vanrenterghem, Y., & Evenepoel, P. (2008) · Kidney International · doi:10.1038/ki.2008.31 · Cited by 315
Schepers, E., Meert, N., Glorieux, G., Goeman, J., Van der Eycken, J., & Vanholder, R. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl584 · Cited by 296
Removal of P-Cresol Sulfate by Hemodialysis
Martinez, A. W., Recht, N. S., Hostetter, T. H., & Meyer, T. W. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005030310 · Cited by 262
Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells
Yamamoto, H., Tsuruoka, S., Ioka, T., Ando, H., Ito, C., Akimoto, T., Fujimura, A., Asano, Y., & Kusano, E. (2006) · Kidney International · doi:10.1038/sj.ki.5000340 · Cited by 247
The Uremic Retention Solute p-Cresyl Sulfate and Markers of Endothelial Damage
Meijers, B. K. I., Van kerckhoven, S., Verbeke, K., Dehaen, W., Vanrenterghem, Y., Hoylaerts, M. F., & Evenepoel, P. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.04.022 · Cited by 242
Keane, W. F., Zhang, Z., Lyle, P. A., Cooper, M. E., de Zeeuw, D., Grunfeld, J.-P., Lash, J. P., McGill, J. B., Mitch, W. E., Remuzzi, G., et al. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01381005 · Cited by 202
Schulman, G., Agarwal, R., Acharya, M., Berl, T., Blumenthal, S., & Kopyt, N. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.12.036 · Cited by 200
Niwa, T., Nomura, T., Sugiyama, S., Miyazaki, T., Tsukushi, S., & Tsutsui, S. (1997) · PubMed · Cited by 200
Miyazaki, T., Ise, M., Seo, H., & Niwa, T. (1997) · PubMed · Cited by 192
de Loor, H., Bammens, B., Evenepoel, P., De Preter, V., & Verbeke, K. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.050781 · Cited by 186
p-Cresyl Sulfate and Indoxyl Sulfate in Hemodialysis Patients
Meijers, B. K. I., De Loor, H., Bammens, B., Verbeke, K., Vanrenterghem, Y., & Evenepoel, P. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02940509 · Cited by 177
Kent, D. M., Jafar, T. H., Hayward, R. A., Tighiouart, H., Landa, M., de Jong, P., de Zeeuw, D., Remuzzi, G., Kamper, A.-L., & Levey, A. S. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006101081 · Cited by 162
Akizawa, T., Asano, Y., Morita, S., Wakita, T., Onishi, Y., Fukuhara, S., Gejyo, F., Matsuo, S., Yorioka, N., & Kurokawa, K. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.05.011 · Cited by 158
Indoxyl sulfate induces complex redox alterations in mesangial cells
Gelasco, A. K., & Raymond, J. R. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00281.2004 · Cited by 122
Indoxyl Sulfate Reduces Superoxide Scavenging Activity in the Kidneys of Normal and Uremic Rats
Owada, S., Goto, S., Bannai, K., Hayashi, H., Nishijima, F., & Niwa, T. (2007) · American Journal of Nephrology · doi:10.1159/000112823 · Cited by 114
Shimizu, H., Hirose, Y., Nishijima, F., Tsubakihara, Y., & Miyazaki, H. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00206.2009 · Cited by 106
P-cresol, a uremic toxin, decreases endothelial cell response to inflammatory cytokines
Dou, L., Cérini, C., Brunet, P., Guilianelli, C., Moal, V., Grau, G. E., Smet, R. D., Vanholder, R., Sampol, J., & Berland, Y. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.t01-1-00651.x · Cited by 96
New insights into uremic toxicity
Raff, A. C., Meyer, T. W., & Hostetter, T. H. (2008) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32830f45b6 · Cited by 91
Ueda, H., Shibahara, N., Takagi, S., Inoue, T., & Katsuoka, Y. (2007) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2007.00430.x · Cited by 83
Shoji, T., Wada, A., Inoue, K., Hayashi, D., Tomida, K., Furumatsu, Y., Kaneko, T., Okada, N., Fukuhara, Y., Imai, E., et al. (2006) · Nephron Clinical Practice · doi:10.1159/000097985 · Cited by 75
Shimizu, H., Okada, S., Oh‐I, S., et al. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2590 · Cited by 14
Cited by
Microbial tryptophan catabolites in health and disease
Roager, H. M., & Licht, T. R. (2018) · Nature Communications · doi:10.1038/s41467-018-05470-4 · Cited by 2,236
Gut microbiota in cardiovascular health and disease
Tang, W. H. W., Kitai, T., & Hazen, S. L. (2017) · Circulation Research · doi:10.1161/circresaha.117.309715 · Cited by 1,670
Kalantar-Zadeh, K., Jafar, T. H., Nitsch, D., Neuen, B. L., & Perkovic, V. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00519-5 · Cited by 1,461
The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease
Yang, T., Richards, E. M., Pepine, C. J., & Raizada, M. K. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0018-2 · Cited by 753
The Gut Microbiome, Kidney Disease, and Targeted Interventions
Ramezani, A., & Raj, D. S. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013080905 · Cited by 743
Metadata
- Authors
- Wu, I.-W., Hsu, K.-H., Lee, C.-C., Sun, C.-Y., Hsu, H.-J., Tsai, C.-J., Tzen, C.-Y., Wang, Y.-C., Lin, C.-Y., & Wu, M.-S.
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-09-29
- Volume
- 26
- Issue
- 3
- Pages
- 938-947
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2129559166
- Cited by
- 510
- References
- 29
- FWCI
- 8.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.